Mutations in tumor-suppressor genes are associated with many types of cancers. In addition, epigenetic changes (such as DNA methylation) of tumor-suppressor genes are also associated with tumorigenesis [Otani et al. (2013). Expert Rev Mol Diagn 13:445–455].

How might hypermethylation of the TP53 gene promoter influence tumorigenesis?

Key Concepts

Tumor-Suppressor Genes

Tumor-suppressor genes are critical components of the cellular machinery that regulate cell growth and division. They function to prevent uncontrolled cell proliferation, and mutations in these genes can lead to cancer. The TP53 gene, often referred to as the 'guardian of the genome,' plays a vital role in maintaining genomic stability and initiating apoptosis in response to DNA damage.

DNA Methylation

DNA methylation is an epigenetic modification involving the addition of a methyl group to the DNA molecule, typically at cytosine bases. This process can regulate gene expression without altering the underlying DNA sequence. Hypermethylation of promoter regions, such as that of the TP53 gene, can silence gene expression, leading to the loss of tumor-suppressive functions and contributing to tumorigenesis.

Tumorigenesis

Tumorigenesis is the process by which normal cells transform into cancerous cells, involving a series of genetic and epigenetic changes. This process can be driven by mutations, epigenetic alterations, and environmental factors. The inactivation of tumor-suppressor genes, such as through hypermethylation, is a key event in tumorigenesis, allowing for unchecked cell growth and proliferation.